Tianweiyuan and Biomedicine (Shanghai) Co.
Latest round
- Series A
Last raised
- Dec 2021
Total raised
- $20M
Investors
- 3
About Tianweiyuan and Biomedicine (Shanghai) Co.
a., operates as a biotechnology company that focuses on tumor immunotherapy. The company provides tumor immunotherapy drugs for hematopoietic cancers and non-hematopoietic cancers such as acute lymphoblastic leukemia (ALL), liver and bile duct cancer, lung, pancreas, stomach, and colon cancer, etc. The firm has developed an immunotherapy antibody technology platform called iTAb™, which applies the T cell engager (TCE) mechanism to kill and eliminate tumor cells in cancer patients. The iTAb product pipeline includes CD3 T cell engagers, A-319, and A-337, which are currently in the phase I clinical development stage. The company plans to deploy the funds for further development of products derived from the iTAb™ platform.
Who invested in Tianweiyuan and Biomedicine (Shanghai) Co.
3 investors across 1 round
See all investors in Tianweiyuan and Biomedicine (Shanghai) Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 1, 2021
Amount
$20M
Investors
Questions about Tianweiyuan and Biomedicine (Shanghai) Co.
Who invested in Tianweiyuan and Biomedicine (Shanghai) Co.?
Tianweiyuan and Biomedicine (Shanghai) Co. has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tianweiyuan and Biomedicine (Shanghai) Co. raised?
Tianweiyuan and Biomedicine (Shanghai) Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Tianweiyuan and Biomedicine (Shanghai) Co. last raise money?
Tianweiyuan and Biomedicine (Shanghai) Co.'s most recent round on record is a Series A, in Dec 2021.
What does Tianweiyuan and Biomedicine (Shanghai) Co. do?
Tianweiyuan and Biomedicine (Shanghai) Co. is a biotechnology company.
Where is Tianweiyuan and Biomedicine (Shanghai) Co. headquartered?
Tianweiyuan and Biomedicine (Shanghai) Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Tianweiyuan and Biomedicine (Shanghai) Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Tianweiyuan and Biomedicine (Shanghai) Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Tianweiyuan and Biomedicine (Shanghai) Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.